Akiyoshi T, Koba F, Arinaga S, Wada T, Tsuji H
Jpn J Surg. 1985 Sep;15(5):375-8. doi: 10.1007/BF02469933.
Effect of exogenous interleukin 2 (IL 2) on the postoperative depression of cell-mediated immune response in vitro was studied in 8 patients with benign lesion and 11 patients with various carcinoma, undergoing major surgical procedures. When peripheral blood mononuclear cells (PBM) were obtained from patients 3 days after surgery, the proliferative response of PBM in mixed lymphocyte culture (MLC) was significantly decreased, as compared to that before operation. The depressed proliferative response was significantly increased and improved to the preoperative level, when exogenous IL 2 was added at a concentration of 50 per cent in culture. The defective generation of cytotoxic cells in MLC 3 days after operation was also significantly augmented and improved to the preoperative range by addition of 25 per cent IL 2 in culture. IL 2 produced minimal increase in these responses when PBM were obtained preoperatively. There was no significant difference between each value in these responses obtained from patients with benign lesion and carcinoma. These results show that PBM from patients who had undergone major surgery were responsive to exogenous IL 2. The postoperative depression of cell-mediated immune response may be reversible with exogenous IL 2.
研究了外源性白细胞介素2(IL-2)对8例良性病变患者和11例各种癌症患者在接受大手术过程中术后细胞介导免疫反应体外抑制的影响。术后3天从患者获取外周血单个核细胞(PBM)时,与术前相比,PBM在混合淋巴细胞培养(MLC)中的增殖反应显著降低。当在培养物中添加浓度为50%的外源性IL-2时,降低的增殖反应显著增加并改善至术前水平。术后3天MLC中细胞毒性细胞生成缺陷也通过在培养物中添加25%的IL-2而显著增强并改善至术前范围。术前获取PBM时,IL-2使这些反应的增加最小。从良性病变患者和癌症患者获得的这些反应中的各值之间无显著差异。这些结果表明,接受大手术患者的PBM对外源性IL-2有反应。细胞介导免疫反应的术后抑制可能可通过外源性IL-2逆转。